Brain Substance Clearance via Multi-Electrode Electrical Drive
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Alzheimer's disease and cerebral amyloid angiopathy are inadequate in effectively clearing amyloid beta and tau proteins from the brain, which are believed to contribute to the progression of these conditions.
Innovation Solution
The use of parenchymal and cerebrospinal fluid electrodes, implanted in the brain parenchyma and CSF-filled spaces respectively, with control circuitry to drive these electrodes to clear substances like amyloid beta and tau proteins from the brain parenchyma into the CSF-filled spaces, and potentially from there to the superior sagittal sinus, using electrical techniques such as direct current application.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If electrical techniques are applied to clear substances from the brain, then the effectiveness of clearing amyloid beta and tau proteins is improved, but the device complexity increases due to the need for implanted electrodes and control circuitry
Solution Approach 1:
The system is divided into distinct functional components: parenchymal electrodes for substance clearance, CSF electrodes for fluid management, and control circuitry for coordinating operation. This segmentation allows each component to be optimized for its specific function while maintaining overall system effectiveness.
Solution Approach 2:
The patent uses the cerebrospinal fluid (CSF) as an intermediary medium to transport cleared substances from the brain parenchyma to the subarachnoid space. This natural fluid pathway serves as a mediator that facilitates substance removal without requiring direct external extraction mechanisms.
2Reliability
If electrodes are implanted in the brain parenchyma and CSF-filled spaces, then the ability to clear pathological substances is improved, but the ease of operation deteriorates due to the invasive nature of the procedure
Solution Approach 1:
The control circuitry is designed to perform multiple functions through a single integrated system: it coordinates parenchymal electrode stimulation for substance clearance, manages CSF electrode positioning, and regulates electrical parameter delivery. This multi-functionality reduces the need for separate devices and simplifies overall system operation.
Solution Approach 2:
The system leverages the brain's own cerebrospinal fluid circulation mechanisms to facilitate substance removal. Once substances are mobilized from the parenchyma by electrical stimulation, the natural CSF flow carries them away without requiring additional active pumping or mechanical intervention, allowing the body's own physiology to serve the treatment function.
3Productivity
If direct current is applied between electrodes to clear substances, then the productivity of substance removal is improved, but the loss of energy increases due to continuous electrical application
Solution Approach 1:
The control circuitry delivers electrical stimulation in periodic pulses rather than continuous direct current. This pulsed delivery pattern maintains effective substance clearance while allowing intervals for tissue recovery and reducing cumulative energy consumption. The periodic action optimizes the balance between clearance productivity and energy efficiency.
Solution Approach 2:
The system maintains continuous substance clearance effectiveness through coordinated multi-electrode operation. While individual electrodes receive pulsed stimulation, the overall system achieves continuous clearance by having multiple electrodes operating in sequence or parallel, ensuring that substance removal is ongoing without interruption despite the pulsed electrical delivery pattern.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach potentially slows the progression of Alzheimer's disease and cerebral amyloid angiopathy by effectively removing pathological substances from the brain, thereby addressing the accumulation of amyloid beta and tau proteins.
Implementation Method 1
using electrical techniques such as direct current application
Implementation Method 2
clear a substance from the brain parenchyma into the CSF-filled space of the brain
Data Source
AI summary
A method is provided that includes implanting (a) a parenchymal electrode in or in contact with an outer surface of brain parenchyma of a subject identified as at risk of or suffering from a disease, and (b) a cerebrospinal fluid (CSF) electrode in a CSF-filled space of a brain of the subject, the CSF-filled space selected from the group consisting of: a ventricular system and a subarachnoid space. A midplane treatment electrode is disposed in or over a superior sagittal sinus. Control circuitry is activated to drive the parenchymal electrode and the CSF electrode to drive a substance from the brain parenchyma into the CSF-filled space of the brain, and apply a treatment current between the CSF electrode and the midplane treatment electrode to drive the substance from the CSF-filled space of the brain to the superior sagittal sinus. Other embodiments are also described.